Table 2

Clinical data, IGF-1, and IGFB-3 for Nordic walking group and low-intensity walking group

Nordic walking

Low-intensity walking

Difference in change between groups at

at 15 weeks

Difference in change between groups at

at 30 weeks


Baseline

15 weeks to 0 weeks

30 weeks to 0 weeks

Baseline

15 weeks to 0 weeks

30 weeks to 0 weeks


Median (range)

Diff

median (range)

P valuea

Diff

median (range)

P valuea

Median (range)

Diff

median (range)

P valuea

Diff

median (range)

P valuea

P valueb

P valueb


Pain threshold

kPa

199.2 (106.2 to 372.3)

-6.6 (-84.6 to 75.6)

P = 0.454

13.9 (-109.2 to 94.1)

P = 0.278

215.4 (105.9 to 380.5)

-13.7 (-102.1 to 36.8)

P = 0.031

-12.8 (-165.2 to 108.5)

P = 0.689

P = 0.169

P = 0.339


Pain

mm

70.5 (7 to 98)

-0.5 (-40 to 25) P = 0.416

-1 (-39 to 53) P = 0.988

75 (10 to 92)

-7 (-27 to 35) P = 0.067

-4 (-34 to 29) P = 0.218

P = 0.356

P = 0.432


6MWT

m

520 (381 to 660)

36.5 (-44 to 164.5) P < 0.001

29.3 (-150.5 to 145) P = 0.006

516 (428 to 656)

8 (-77 to 107) P = 0.183

-2 (-62.5 to 103) P = 0.520

P = 0.033

P = 0.049


IGF-1

ng/ml

4.3 (0 to 15.6)

-0,2 (-11.4 to 28.7) P = 0.300

-0.7 (-12.7 to 1.7) P = 0.019

3.3 (0 to 35.7)

-0.3 (-31.6 to 1.9) P = 0.148

-0.1 (-31.2 to 1.4) P = 0.109

P = 0.795

P = 0.570


IGFB3

ng/ml

1,449.2 (546.6 to 3,288.3)

-57.4 (-1,524.7 to 1,846.6) P = 0.977

291.1 (-1,383.3 to 2,821.8) P = 0.426

1,680.9 (269.5 to 3,274.2)

-33.5 (-1551.7 to 1,198.8) P = 0.881

242 (-1563 to 1,558.2) P = 0.796

P = 0.906

P = 0.872


aWilcoxon signed rank test. bMann-Whitney U test. Median, range (min-max) for baseline, as well as median differences and P values at 15 and 30 weeks, are presented.

Bjersing et al. Arthritis Research & Therapy 2012 14:R162   doi:10.1186/ar3902

Open Data